![](/img/cover-not-exists.png)
Improved tolerability by a modified intermittent treatment schedule of dasatinib for patients with chronic myeloid leukemia resistant or intolerant to imatinib
Paul La Rosée, Philippe Martiat, Armin Leitner, Thomas Klag…Volume:
92
Language:
english
DOI:
10.1007/s00277-013-1769-2
Date:
October, 2013
File:
PDF, 151 KB
english, 2013